DK0586621T3 - Linsidomin til behandling af erektile dysfunktioner - Google Patents

Linsidomin til behandling af erektile dysfunktioner

Info

Publication number
DK0586621T3
DK0586621T3 DK92924464T DK92924464T DK0586621T3 DK 0586621 T3 DK0586621 T3 DK 0586621T3 DK 92924464 T DK92924464 T DK 92924464T DK 92924464 T DK92924464 T DK 92924464T DK 0586621 T3 DK0586621 T3 DK 0586621T3
Authority
DK
Denmark
Prior art keywords
pct
treatment
sec
combination
date
Prior art date
Application number
DK92924464T
Other languages
English (en)
Inventor
Christian Dr Stief
Original Assignee
Christian Dr Stief
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Christian Dr Stief filed Critical Christian Dr Stief
Application granted granted Critical
Publication of DK0586621T3 publication Critical patent/DK0586621T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Electrotherapy Devices (AREA)
  • Medicinal Preparation (AREA)
DK92924464T 1991-05-27 1992-05-14 Linsidomin til behandling af erektile dysfunktioner DK0586621T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4117249A DE4117249C2 (de) 1991-05-27 1991-05-27 Linsidomin zur Behandlung erektiler Dysfunktionen
PCT/EP1992/001109 WO1992021346A1 (de) 1991-05-27 1992-05-14 Linsidomin zur behandlung erektiler dysfunktionen

Publications (1)

Publication Number Publication Date
DK0586621T3 true DK0586621T3 (da) 2000-09-18

Family

ID=6432511

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92924464T DK0586621T3 (da) 1991-05-27 1992-05-14 Linsidomin til behandling af erektile dysfunktioner

Country Status (11)

Country Link
US (1) US5492911A (da)
EP (1) EP0586621B1 (da)
AT (1) ATE195870T1 (da)
AU (1) AU1877992A (da)
CA (1) CA2110275A1 (da)
DE (2) DE4117249C2 (da)
DK (1) DK0586621T3 (da)
ES (1) ES2150425T3 (da)
GR (1) GR3034519T3 (da)
HU (1) HU9303359D0 (da)
WO (1) WO1992021346A1 (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242391A (en) * 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
DE4305881C1 (de) * 1993-02-26 1994-03-03 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Wirkstoffen, welche Stichoxid-Quellen darstellen, Verfahren zu seiner Herstellung sowie seine Verwendung
CA2215307A1 (en) * 1995-03-14 1996-09-19 Vivus, Incorporated Pharmaceutical compositions and kits for preventing erectile dysfunction
US5741511A (en) * 1995-04-12 1998-04-21 Sam Yang Co., Ltd. Transdermal drug delivery device for treating erectile dysfunction
US5718917A (en) * 1995-12-15 1998-02-17 Harvard Scientific Corporation PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
US20050065161A1 (en) * 1996-02-02 2005-03-24 Nitromed, Inc. Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
US20020143007A1 (en) * 1996-02-02 2002-10-03 Garvey David S. Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
US6323211B1 (en) 1996-02-02 2001-11-27 Nitromed, Inc. Compositions and methods for treating sexual dysfunctions
US6469065B1 (en) 1996-02-02 2002-10-22 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use
US6294517B1 (en) 1996-02-02 2001-09-25 Nitromed, Inc. Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use
US5958926A (en) 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
USRE37234E1 (en) * 1996-11-01 2001-06-19 Nitromed, Inc. Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses
US6331543B1 (en) 1996-11-01 2001-12-18 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
US5939090A (en) * 1996-12-03 1999-08-17 3M Innovative Properties Company Gel formulations for topical drug delivery
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
FR2774594A1 (fr) * 1998-02-12 1999-08-13 Philippe Gorny Medicament destine notamment a prevenir ou traiter les dysfonctions erectiles
US6187790B1 (en) 1999-03-04 2001-02-13 Neal R. Cutler Use of cilostazol for treatment of sexual dysfunction
US6132757A (en) 1998-05-01 2000-10-17 Neal R. Cutler Treatment of sexual dysfunction in certain patient groups
US6426084B1 (en) 2000-06-19 2002-07-30 Neal R. Cutler Treatment of sexual dysfunction in certain patient groups
US6194433B1 (en) 1998-10-05 2001-02-27 Neal R. Cutler Sexual dysfunction in females
US6110489A (en) * 1998-05-01 2000-08-29 Cutler; Neal R. Use of quinolines and quinolones to treat male erectile dysfunction
CA2319542C (en) * 1998-05-01 2005-07-12 Rt Alamo Ventures, Inc. The treatment of sexual dysfunction in certain patient groups
US6132753A (en) * 1998-05-01 2000-10-17 Neal R. Cutler Treatment of sexual dysfunction in certain patient groups
US5942545A (en) * 1998-06-15 1999-08-24 Macrochem Corporation Composition and method for treating penile erectile dysfunction
JP2002518351A (ja) * 1998-06-19 2002-06-25 オキシバイオ・インコーポレイテッド 抗感染および避妊特性を有する医療装置
HUP0103206A3 (en) 1998-06-25 2002-11-28 Lavipharm Lab Inc Piscataway A device and method for the treatment of erectile dysfunction and for its making
US7087240B1 (en) 1998-06-25 2006-08-08 Lavipharm Laboratories Inc. Device and method for the treatment of erectile dysfunction
FR2786699B1 (fr) * 1998-12-02 2002-10-04 Philippe Gorny Medicament destine notamment a prevenir ou traiter les dysfonctions sexuelles
WO2000035434A2 (en) * 1998-12-14 2000-06-22 Cellegy Pharmaceuticals, Inc. Compositions and methods for the treatment of anorectal disorders
US6627632B2 (en) * 1998-12-14 2003-09-30 Cellegy Pharmaceuticals, Inc. Compositions and methods for the treatment of anorectal disorders
AU3713600A (en) * 1999-03-01 2000-09-21 Nitromed, Inc. Nitrosated and nitrosylated prostaglandins, compositions and metods of use
FR2793689B1 (fr) * 1999-05-19 2001-08-24 Pf Medicament Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives
US6838050B1 (en) 1999-06-04 2005-01-04 Oxibio, Inc. Methods and devices for providing anti-infective activity to a medical device
US6303135B1 (en) 1999-07-08 2001-10-16 Neal R. Cutler Use of quinolines and quinolones to treat male erectile dysfunction
US6436944B1 (en) * 1999-09-30 2002-08-20 Pfizer Inc. Combination effective for the treatment of impotence
DE10021894A1 (de) * 2000-05-05 2001-11-29 Ilias Papadopoulos Pharmazeutisches Präparat zur Diagnose und Behandlung der erektilen Dysfunktion
DE10111516A1 (de) * 2001-03-09 2002-09-12 Judith Carlen Verwendung von Sydnoniminen zur spezifischen Diagnose erektiler Dysfunktionen
US20090197892A1 (en) * 2007-08-21 2009-08-06 Nawaz Ahmad Anhydrous compositions useful for attaining enhanced sexual wellness

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1496056A (fr) * 1964-06-08 1967-09-29 Takeda Chemical Industries Ltd Nouveaux composés chimiques du type sydnonimine
JPS5832870A (ja) * 1981-08-24 1983-02-25 Hiroyoshi Hidaka 新規なシドノンイミン誘導体及びその製法
JPS60156671A (ja) * 1984-01-25 1985-08-16 Yamanouchi Pharmaceut Co Ltd ジヒドロピリジン誘導体およびその製造法
US4687771A (en) * 1985-11-01 1987-08-18 Bristol-Myers Company Method for treatment of male impotence
US4840952A (en) * 1985-11-01 1989-06-20 Bristol-Myers Company Method for treatment of male impotence
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment
US5256652A (en) * 1987-11-12 1993-10-26 Pharmedic Co. Topical compositions and methods for treatment of male impotence
US4931445A (en) * 1988-10-06 1990-06-05 Irwin Goldstein Agents for treatment of male impotence
DE3943519A1 (de) * 1989-04-27 1991-01-17 Stief Georg Arzneimittel zur behandlung erektiler dysfunktionen
US5059603A (en) * 1989-06-12 1991-10-22 Centuries Laboratories, Inc. Method and composition for treating impotence
FR2649613B1 (fr) * 1989-07-11 1991-09-27 Virag Ronald Medicament vaso-actif
US5236904A (en) * 1989-09-18 1993-08-17 Senetek, Plc Erection-inducing methods and compositions
HU211648A9 (en) * 1990-03-28 1995-12-28 Chinoin Gyogyszer Es Vegyeszet Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same
DE4031373A1 (de) * 1990-10-04 1992-04-09 Cassella Ag 3-piperazino-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung
US5267963A (en) * 1992-08-21 1993-12-07 Nicholas Bachynsky Medication injection device

Also Published As

Publication number Publication date
EP0586621A1 (de) 1994-03-16
GR3034519T3 (en) 2000-12-29
DE59209860D1 (de) 2000-10-05
ES2150425T3 (es) 2000-12-01
DE4117249A1 (de) 1992-12-03
DE4117249C2 (de) 1998-05-14
WO1992021346A1 (de) 1992-12-10
AU1877992A (en) 1993-01-08
CA2110275A1 (en) 1992-12-10
ATE195870T1 (de) 2000-09-15
EP0586621B1 (de) 2000-08-30
HU9303359D0 (en) 1994-03-28
US5492911A (en) 1996-02-20

Similar Documents

Publication Publication Date Title
ES2150425T3 (es) Linsidomina para el tratamiento de disfunciones erectiles.
MX9307885A (es) Aplicacion de la carbamzaepina y oxcarbazepian para la obtencion de medicamentos para el tratamiento de la enfermedad de parkinson y los sindromes parkinsonianos.
BR0108379A (pt) Composições de liberação controlada contendo agonista e antagonista opióide, método para a preparação de uma formulação em dosagem de analgésico opióide de liberação controlada com potência analgésica aumentada e sistema de administração através da derme para um analgésico opióide
BR0115392A (pt) Método para o tratamento de uma doença sensìvel a interferona em um animal de sangue quente, método para individualizar as dosagens de uma interferona no tratamento, método para a fabricação de um dispositivo de liberação de efeito terapêutico de longa duração de uma droga ao longo de um perìodo de tempo, e conjunto útil para a ministração de uma quantidade relativamente constante de uma droga
DE69225135D1 (de) Dosierungsform zur verzoegerten wirkstofffreisetzung
FR2622798B1 (fr) Forme d'apport dose et dispositif osmotique d'administration d'un medicament pour le traitement de maladies cardio-vasculaires
ZA888461B (en) Azelastine-containing medicaments for application in the nose and/or at the eye
DE60022021D1 (de) Zubereitungen enthaltend Apomorphin und Sildenafil und ihre Verwendung zur Behandlung von erektiler Dysfunktion
FI972542A0 (fi) Transdermaalijärjestelmä useamman aktiivisen aineen samanaikaista antamista varten
ES2196361T3 (es) Combinaciones terapeuticas de antagonistas de rar y agonistas de rxr.
ES2171469T3 (es) Composicion administrada por via nasal y preparacion que la contiene.
NO20043871L (no) Legemiddelformuleringer med kontrollert frigjoring som inneholder et baererpeptid
AR016798A1 (es) Uso de una cepa de lactobacillus para la elaboracion de un medicamento
ES2183841T3 (es) Formas de dosificacion para administrar un farmasco en una formulacion lquidid.
YU2494A (sh) Farmaceutska formulacija za tretiranje zavisnosti od nikotina
SE0002754D0 (sv) New pharmaceutical combination formulation and method of treatment with the combination
MX9203444A (es) Medicamentos.
ES2168241T1 (es) Preparacion farmaceutica que contiene tolperisona para administrar por via oral.
ES2135342B1 (es) Uso del raloxifeno o una sal o salvato del mismo en la preparacion de un medicamento para prevenir el cancer de mama.
EE03385B1 (et) Angiotensiini II tüüp 1 retseptori antagonistide kasutamine düspeptiliste sümptomite profülaktikas ja/või ravis kasutatava ravimi valmistamiseks ja angiotensiini II tüüp 1 retseptori antagoniste sisaldavad ravimpreparaadid
ES2094834T3 (es) Dispositivo para el lavado, para finalidades terapeuticas o de higiene, de conductos internos humanos o animales.
KR890007728A (ko) 진통제 제조방법
GR3024854T3 (en) Drugs for preventing the development of tolerance during treatment with benzodiazepine-receptor-binding substances.
BR9912260A (pt) Emplastro contendo um sistema terapêutico transdérmico e dose única para ministração
ES2146683T3 (es) Uso de bifemelano para la fabricacion de un medicamento para el tratamiento de trastornos hipercineticos.